Reference no: EM131016692

1. For questions 1 - 6:

   Given treatments:

   A: cost $4,000, 60% survival

   B: cost: $7,000, 63% survival

   C: cost $11,000, 61% survival

   D: cost $10,000, 74% survival

   No intervention: 11% survival 

   Which treatment is obviously dominated?

   a.	A
   b.	B
   c.	C
   d.	D
   e.	no treatment is obviously dominated

3 points   

QUESTION 6

1. From the previous question.  What is the ICER from treatment A to B?

   a.	$10,000
   b.	$100,000
   c.	$42,857
   d.	$1 million
   e.	none of the above

QUESTION 7

1. Given Question 5 Which treatments comprise the Cost Effectiveness Frontier?

   a.	A, B, C, and D
   b.	A and D
   c.	A, C, and D
   d.	A, B, and D

QUESTION 8

1. What impact does insurance (or having more beneficial insurance) have on a Cost effectiveness Frontier?

   a.	nothing
   b.	shifts the frontier to the right
   c.	shifts the frontier to the left
   d.	cannot be determined

QUESTION 9

1. What can we add to the CEF to turn this cost effectiveness tool into a Cost Benefit tool?

   a.	insurance
   b.	moral hazard
   c.	indifference curves
   d.	premium rates

QUESTION 10

1. For year 1 after the surgery, Dlanod's probability of survival is 0.7 and  his q value is 0.6. Assuming a discount factor of 0.91, what is his QALY for year 1?  (rounded-off)

   a.	0.92
   b.	2.21
   c.	0.81
   d.	0.38

QUESTION 11

1. In addition to info in Question 10, In year 2, survival rate will be 0.7, quality of life = 0.6 and the discount factor = 0.83

   What is the total QALY for the 2 years?

   a.	0.35
   b.	0.73
   c.	1.2
   d.	2.59
   e.	3.02

QUESTION 12

1. Which HTA requires benefits to have dollar values?

   a.	Cost Effectiveness Analysis
   b.	Cost Effectiveness Ratio
   c.	Cost Benefit Analysis
   d.	Incremental Cost Effectiveness Ratio